Similar Articles
-
Use of Chromogenic Assay of Factor X to Accept or Reject INR Results in Warfarin Treated Patients
Michael J. Sanfelippo, Wendy Zinsmaster, Doris L. Scherr and Gene R. Shaw- Clinical Medicine & Research September 2009, 7 (3) 103-105;
- DOI: https://doi.org/10.3121/cmr.2009.836
-
PS3-4: Genetic Risk Factors for Major Bleeding in Warfarin Patients in a Community Setting
Joshua Roth, Denise Boudreau, Monica Fujii, Federico Farin, Allan Rettie, Kenneth Thummel and David Veenstra- Clinical Medicine & Research September 2013, 11 (3) 148;
- DOI: https://doi.org/10.3121/cmr.2013.1176.ps3-4
-
Evaluation of Genetic Factors for Warfarin Dose Prediction
Michael D. Caldwell, Richard L. Berg, Kai Qi Zhang, Ingrid Glurich, John R. Schmelzer, Steven H. Yale, Humberto J. Vidaillet and James K. Burmester- Clinical Medicine & Research March 2007, 5 (1) 8-16;
- DOI: https://doi.org/10.3121/cmr.2007.724
-
PS2-32: Disparities in Oral Capecitabine Use: A Chart Review of Older Patients Treated in the Community
Pamala Pawloski, Eric Moeker and Gary Shapiro- Clinical Medicine & Research September 2014, 12 (1-2) 79;
- DOI: https://doi.org/10.3121/cmr.2014.1250.ps2-32
-
C-B1-02: Strategies Used by Physicians to Treat Hypertension
William Rush, Patrick O’Connor, JoAnn Sperl-Hillen and Heidi Ekstrom- Clinical Medicine & Research December 2010, 8 (3-4) 180;
- DOI: https://doi.org/10.3121/cmr.2010.943.c-b1-02
-
Understanding Patient Preference of Providers to Treat Foot and Ankle Disorders
Jonathan Kraus, Alexander Nielsen, Brian Law, Glenn Shi and Gunnar Whealy- Clinical Medicine & Research January 2022, cmr.2021.1631;
- DOI: https://doi.org/10.3121/cmr.2021.1631
-
Understanding Patient Preference of Providers to Treat Foot and Ankle Disorders
Jonathan Kraus, Alexander Nielsen, Brian Law, Glenn Shi and Gunnar Whealy- Clinical Medicine & Research March 2022, 20 (1) 40-45;
- DOI: https://doi.org/10.3121/cmr.2021.1631
-
Initiation of Warfarin in Hospitals
Suhail A.R. Doi- Clinical Medicine & Research December 2007, 5 (4) 207-208;
- DOI: https://doi.org/10.3121/cmr.2007.777
-
Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures
Lucas G Leonhard, Richard L Berg, James K Burmester, Joseph J Mazza, John R Schmelzer and Steven H Yale- Clinical Medicine & Research June 2014, cmr.2014.1208;
- DOI: https://doi.org/10.3121/cmr.2014.1208
-
Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures
Lucas G Leonhard, Richard L Berg, James K Burmester, Joseph J Mazza, John R Schmelzer and Steven H Yale- Clinical Medicine & Research June 2014, cmr.2014.1208;
- DOI: https://doi.org/10.3121/cmr.2014.1208